Hutson Nancy J
SEC CIK 1379222 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BCRX | BIOCRYST PHARMACEUTICALS INC | Dir | 99.1K | $31.9K | $1.77M | 9 | 2021-10-15 | 2025-06-12 |
Most active insiders at BCRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Barnes Alane P | CLO | — | $3.46M |
| 2 | HEGGIE THERESA | Dir | — | $504.8K |
| 3 | McKee Amy E | Dir | — | $100.3K |
| 4 | SANDERS MACHELLE | Dir | — | $68.5K |
| 5 | Menon Sandeep | Chief R, D Off | — | — |
| 6 | Ghias Babar | CFO | — | — |
| 7 | Gayer Charles K | Pres, CCO | — | — |
| 8 | Milne Jill C. | Dir | — | — |
| 9 | Frank Steven | Dir | — | — |
| 10 | Galson Steven K | Dir | — | — |
Hutson Nancy J made no open-market trades at BCRX in the last 12 months.
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-16 | 2025-06-12 | BCRX | BIOCRYST PHARMACEUTICALS INC | Hutson Nancy J | Dir | A - Grant | $0.00 | +12.5K | 99.1K | +14% | $0 |
| 2024-12-16 | 2024-12-13 | BCRX | BIOCRYST PHARMACEUTICALS INC | Hutson Nancy J | Dir | S - Sale | $7.54 | -7,000 | 86.6K | -7% | -$52.8K | |
| D | 2024-06-14 | 2024-06-12 | BCRX | BIOCRYST PHARMACEUTICALS INC | Hutson Nancy J | Dir | A - Grant | $0.00 | +6,820 | 93.6K | +8% | $0 |
| 2024-05-22 | 2024-05-20 | BCRX | BIOCRYST PHARMACEUTICALS INC | Hutson Nancy J | Dir | P - Purchase | $6.38 | +5,000 | 86.8K | +6% | +$31.9K | |
| D | 2023-06-15 | 2023-06-14 | BCRX | BIOCRYST PHARMACEUTICALS INC | Hutson Nancy J | Dir | S - Sale | $8.04 | -12.9K | 81.8K | -14% | -$103.4K |
| D | 2023-06-15 | 2023-06-13 | BCRX | BIOCRYST PHARMACEUTICALS INC | Hutson Nancy J | Dir | A - Grant | $0.00 | +16.7K | 94.7K | +21% | $0 |
| D | 2022-06-09 | 2022-06-07 | BCRX | BIOCRYST PHARMACEUTICALS INC | Hutson Nancy J | Dir | A - Grant | $0.00 | +12.9K | 77.9K | +20% | $0 |
| DM | 2021-10-19 | 2021-10-15 | BCRX | BIOCRYST PHARMACEUTICALS INC | Hutson Nancy J | Dir | M - OptEx | $3.46 | +105.0K | 170.1K | +161% | +$363.4K |
| D | 2021-10-19 | 2021-10-15 | BCRX | BIOCRYST PHARMACEUTICALS INC | Hutson Nancy J | Dir | S - Sale+OE | $15.40 | -105.0K | 65.1K | -62% | -$1.62M |
Purchase Sale Sale after option exercise All abbreviations